Pro zobrazení tohoto obsahu je třeba být přihlášen.
Author Archives for m.popovic@wemakemedia.cz
EFFICACY BY CYTOGENETIC RISK STATUS FOR DARATUMUMAB IN COMBINATION WITH LENALIDOMIDE AND DEXAMETHASONE OR BORTEZOMIB AND DEXAMETHASONE IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA
4 března, 2021 5:51 pm Leave your thoughtsAuthor(s): Jesus San-Miguel, Katja Weisel, Gordon Cook, et al. Abstract: S 101 Session topic: 14. Myeloma and other...
MNOHOPOČETNÝ MYELÓM
4 března, 2021 5:49 pm Leave your thoughtsNa kongrese EHA 2017 bol mnohopočetnému myelómu (MM) venovaný značný priestor v rámci edukačného a satelitných sympózií, vedeckej pracovnej skupiny a taktiež v posterovej sekcii....
QUIZARTINIB (AC220) IN PATIENTS WITH FLT3-ITD(+) RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA: FINAL RESULTS OF A RANDOMIZED PHASE 2 STUDY
4 března, 2021 5:37 pm Leave your thoughtsAuthor(s): Nigel Russell, Martin S. Tallman, Stuart Goldberg Abstract: ABSSUB-4757 Session topic: 4. Acute myeloid leukemia – Clinical...
ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) WHO REQUIRE TWO COURSES OF INDUCTION THERAPY TO ACHIEVE COMPLETE REMISSION (CR) SHOULD UNDERGO ALLOGENEIC TRANSPLANT (ALLO-SCT) DURING THE FIRST CR
4 března, 2021 5:32 pm Leave your thoughtsAuthor(s): Hiroaki Shimizu, Hiroshi Handa, Nahoko Hatsumi, et al. Abstract: ABSSUB-4989 Session topic: 4. Acute myeloid leukemia –...
RESULTS OF A PHASE 3, MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY OF AZACITIDINE (AZA) VS CONVENTIONAL CARE REGIMENS (CCR) IN OLDER PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML)
4 března, 2021 5:29 pm Leave your thoughtsAuthor(s): Hervé Dombret, John F. Seymour, Aleksandra Butrym, et al. Abstract: LB-6212 Session topic: 4. Acute myeloid leukemia...
VALIDATION OF EUROPEAN LEUKEMIA NET (ELN) GUIDELINES FOR CYTOGENETICALLY NORMAL AML IN ASSOCIATION WITH NPM1 AND FLT3-ITD MUTATIONS: FURTHER STRATIFICATION FOCUSING ON WT1 EXPRESSION
4 března, 2021 5:26 pm Leave your thoughtsAuthor(s): Jae-Ho Yoon, Hee-Je Kim, Young-Woo Jeon, et al. Abstract: ABSSUB-3999 Session topic: 4. Acute myeloid leukemia –...
AKUTNÍ MYELOIDNÍ LEUKEMIE – NOVINKY Z KONFERENCE EVROPSKÉ HEMATOLOGICKÉ SPOLEČNOSTI
4 března, 2021 5:08 pm Leave your thoughtsKonference EHA se věnovala extenzivně oblasti preleukemických predispozičních stavů a dále vlivu stárnutí na vznik a léčebné možnosti akutní myeloidní leukemie (AML). V oblastech...
SAFETY AND EFFICACY OF LONG-TERM OPEN-LABEL DOSING OF SUBCUTANEOUS (SC) ROMIPLOSTIM IN CHILDREN WITH IMMUNE THROMBOCYTOPENIA (ITP)
4 března, 2021 4:58 pm Leave your thoughtsAuthor(s): James Bussel, Michael Tarantino, Victor Blanchette, et al. Abstract: P727 Session topic: 32. Platelets disorders Background:...
TREATMENT OF PRIMARY ADULT CHRONIC IMMUNE THROMBOCYTOPENIA (CITP) WITH FOSTAMATINIB, AN ORAL SYK INHIBITOR: RESULTS OF TWO RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 STUDIES
4 března, 2021 4:48 pm Leave your thoughtsAuthor(s): J Bussel, J Mayer, L Cervinek, K Chojnowski, et al. Abstract: S435 Session topic: 32. Platelets disorders...
REAL WORLD EVIDENCE ON DRUG UTILIZATION PATTERNS OF ELTROMBOPAG IN ADULT PATIENTS WITH IMMUNE THROMBOCYTOPENIA: REVIEU (REVOLADE™ [ELTROMBOPAG] IN SELECTED COUNTRIES IN THE EUROPEAN UNION) STUDY
4 března, 2021 4:45 pm Leave your thoughtsAuthor(s): Emilio Ojeda Gutiérrez, Abdulgabar Salama, Jean-François Viallard, et al. Abstract: P 720 Session topic: 32. Platelets disorders...